About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPARIME: Pilot Study of a Target Detection of Malignant Melanoma

COPARIME: Pilot Study of a Target Detection of Malignant Melanoma

NCT01610531·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Nantes University Hospital

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

patients more than 18 years old,
consulting their GP,
assessed at risk for melanoma according to the SAMScore
signed the consent.

The record

StatusCompleted

PhaseNo phase

Taking part4,118

StartedApr 2011

UpdatedJul 27, 2018

Conditions

Patients at Risk for Melanoma

Where1

University Hospital
Nantes, France